↓ Skip to main content

Drug Discovery from Mother Nature

Overview of attention for book
Attention for Chapter 14: Evodiamine and Its Role in Chronic Diseases
Altmetric Badge


26 Dimensions

Readers on

33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Evodiamine and Its Role in Chronic Diseases
Chapter number 14
Book title
Drug Discovery from Mother Nature
Published in
Advances in experimental medicine and biology, October 2016
DOI 10.1007/978-3-319-41342-6_14
Pubmed ID
Book ISBNs
978-3-31-941341-9, 978-3-31-941342-6

Qunyou Tan, Jingqing Zhang


Subash Chandra Gupta, Sahdeo Prasad, Bharat B. Aggarwal


Evodiamine (EVO) is a major alkaloid compound extracted from the dry unripened fruit Evodiae fructus (Evodia rutaecarpa Benth., Rutaceae). EVO has a variety of pharmacological activities, such as anti-obesity, anti-allergenic, analgesic, anti-tumor, anti-ulcerogenic, and neuroprotective activities. EVO has varying efficacies in animal models and humans. Here, the physicochemical properties of EVO are presented, and the EVO's functions and mechanisms of action in various chronic diseases are reviewed. EVO is worth exploring in more depth in the future for its potential use in various chronic diseases.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 4 12%
Student > Bachelor 4 12%
Student > Master 4 12%
Student > Ph. D. Student 3 9%
Other 2 6%
Other 3 9%
Unknown 13 39%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 8 24%
Biochemistry, Genetics and Molecular Biology 5 15%
Nursing and Health Professions 2 6%
Chemistry 2 6%
Agricultural and Biological Sciences 1 3%
Other 2 6%
Unknown 13 39%